Genesys Biologics Private Limited, a active private limited company, was established on 18 November 2014 in Hyderabad, Telangana, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24232TG2014PTC096432. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹2.33 Cr.
It upholds a compliant status. Employing 259 professional, Its leadership includes Kondrella Roopesh (Director), Tulasiramu Chatadi (Whole-Time Director), Venkata Krishna Rao Dasari (Whole-Time Director). Past directors included Kondrella Rakesh Rao, Tulasiramu Chatadi, Venkata Krishna Rao Dasari. It holds ₹58.50 Cr open charges and ₹61.28 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6-3-248/1/1/A, 4Th Floor Bhaskar Plaza, Road No1,Banjara Hills, Hyderabad, Telangana, 500034.
U24232TG2014PTC096432
096432
18 November 2014
₹3.50 Cr
₹2.33 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Genesys Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kondrella Roopesh | Director | 06 Feb 2015 | Current |
| Tulasiramu Chatadi | Whole-Time Director | 20 Aug 2015 | Current |
| Venkata Krishna Rao Dasari | Whole-Time Director | 20 Aug 2015 | Current |
| Vamshider Joganpally Rao | Director | 18 Nov 2014 | Current |
| Yelma Venkat Reddy | Director | 05 Feb 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Feb 2015 | Past |
| Pramod Abcsdd | Additional Director | 01 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 01 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 27 Oct 2022 | Past |
| Pramod Abcsdd | Director | 27 Oct 2022 | Past |
| Pramod Abcsdd | Director | 31 Jul 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genesys Biologics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Genesys Biologics had a public holding of 42.79%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹585,000,000.00
₹612,750,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2017 | State Bank Of India | ₹58.50 Cr | Open |
| 03 Aug 2018 | State Bank Of India | ₹11.00 Cr | Satisfied |
| 07 Sep 2017 | Others | ₹2.25 M | Satisfied |
| 02 Apr 2017 | State Bank Of India | ₹36.00 Cr | Satisfied |
| 29 Oct 2016 | Others | ₹5.50 M | Satisfied |
Explore comprehensive loan charge details -
Genesys Biologics has a workforce of 259 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Genesys Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genesys Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Genesys Biologics Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge registered on 03 Aug 2018 via Charge ID 100200402 with State Bank Of India was fully satisfied on 30 May 2024. was completed.
Genesys Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity A charge registered on 07 Sep 2017 via Charge ID 100203811 with Others was fully satisfied on 02 Dec 2023. was completed.
A charge registered on 29 Oct 2016 via Charge ID 100203812 with Others was fully satisfied on 02 Dec 2023. was recorded as a recent event.
A charge with State Bank Of India of Rs. 11.00 Cr registered on 03 Aug 2018 with Charge ID 100200402 was modified on 31 Mar 2023. was recorded as a recent event.
The CIN of Genesys Biologics Private Limited is U24232TG2014PTC096432.
Genesys Biologics Private Limited is headquartered at 6-3-248/1/1/A, 4Th Floor Bhaskar Plaza, Road No1,Banjara Hills, Hyderabad, Telangana, 500034.
Genesys Biologics Private Limited was incorporated on 18 November 2014.
The current directors of Genesys Biologics Private Limited are
The primary industry of Genesys Biologics Private Limited is Manufacturing.
Genesys Biologics Private Limited is unlisted.
The authorized capital of Genesys Biologics Private Limited is ₹3.50 Cr, and the paid-up capital is ₹2.33 Cr.
The compliance status of Genesys Biologics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX